Dark | Light
# CG Oncology, Inc.  (CGON)

CG Oncology (CGON) sees soaring social dominance and sentiment following positive bladder cancer trial data. Guggenheim initiates coverage with a 'Buy' rating and $90 target, fueling investor optimism.

### About CG Oncology, Inc.
CG Oncology, Inc. is a biopharmaceutical company focused on developing treatments for bladder cancer.  
CG Oncology, Inc.  uses the ticker $CGON for trading. Listed in the [Stocks](/list/stocks) category.

### Insights
- CG Oncology, Inc.  (CGON) social dominance is up 176% from the previous week.
- CG Oncology, Inc.  (CGON) Galaxy Score™ is up 61.54% from the previous week.
- CG Oncology, Inc.  (CGON) sentiment is up 100% from the previous week.
- CG Oncology, Inc.  (CGON) engagements is up 38.55% from the previous week.
- CG Oncology, Inc.  (CGON) mentions is up 13.01% from the previous week.
- CG Oncology, Inc.  (CGON) posts created is up 184.62% from the previous week.

### Price: $51.50
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$cgon/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$cgon/time-series/close.tsv)  
The stock price is likely increasing due to positive clinical trial data, high sentiment, and a surge in social engagement, supported by a Guggenheim buy rating and target price of $90, despite a recent minor price drop.  

24-Hour: -1.14%
7-Day: 3.71%
30-Day: -5.9%

1-Year High: $57.10 on 2026-01-21  
1-Year Low: $15.60 on 2025-04-08  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$cgon/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$cgon/time-series/alt_rank.tsv)  
CG Oncology, Inc.  (CGON) is currently AltRank #1,638 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [-----] +1,498  
[--] Month: [-----] +682  
[--] Months: [-----] +833  
[--] Year: [-----] +533  
1-Year High: [-----] on 2025-07-05  
1-Year Low: [--] on 2025-04-28  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$cgon/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$cgon/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +16  
[--] Month: [--] [---]  
[--] Months: [--] [---]  
[--] Year: [--] [---]  
1-Year High: [--] on 2025-06-02  
1-Year Low: [--] on 2025-04-01  
  
  
### Engagements: [---] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$cgon/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$cgon/time-series/interactions.tsv)  
Current Value: [---]  
Daily Average: [------]  
[--] Week: [------] +39%  
[--] Month: [-------] -58%  
[--] Months: [---------] -48%  
[--] Year: [---------] +1.30%  
1-Year High: [-------] on 2025-08-10  
1-Year Low: [---] on 2026-02-15  

Engagements by network (24h):
TikTok: [--]
Reddit: [--]
X: [---]
YouTube: [--]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$cgon/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$cgon/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [---] +13%  
[--] Month: [---] -22%  
[--] Months: [-----] +26%  
[--] Year: [-----] +113%  
1-Year High: [---] on 2026-01-10  
1-Year Low: [--] on 2025-09-14  

Mentions by network (24h):
TikTok: [--]
Reddit: [--]
X: [--]
YouTube: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$cgon/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$cgon/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning CG Oncology, Inc.  (CGON) in the last [--] hours which is down 53% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [---] +8.80%  
[--] Month: [---] -25%  
[--] Months: [-----] -7%  
[--] Year: [-----] +99%  
1-Year High: [---] on 2026-01-10  
1-Year Low: [--] on 2025-03-05  
  
  
### Sentiment: 100%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$cgon/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$cgon/time-series/sentiment.tsv)  
Current Value: 100%  
Daily Average: 77%  
[--] Week: 100% +50%  
[--] Month: 100% +18%  
[--] Months: 100% +18%  
[--] Year: 100% +45%  
1-Year High: 100% on 2025-02-20  
1-Year Low: 6% on 2025-03-03  

Most Supportive Themes:
- Positive Clinical Trial Results: (70%) CG Oncology's recent positive clinical trial data for its bladder cancer therapy is a significant driver of investor confidence and positive sentiment.
- Increased Social and Trading Activity: (22%) A notable surge in trading volume and social media engagement indicates growing interest and attention towards CGON.
- Guggenheim Buy Rating: (8%) Guggenheim's initiation of coverage with a 'Buy' rating and a $90 price target provides a strong endorsement and potential upside for the stock.
  
Most Critical Themes:
- Analyst Downgrade: (8%) An unspecified analyst downgrade is creating negative pressure on the stock, despite the otherwise positive news.
  
  
  
### Social Dominance: 0.00292%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$cgon/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$cgon/time-series/social_dominance.tsv)  
Current Value: 0.00292%  
Daily Average: 0.011%  
[--] Week: 0.00276% +0.00176%  
[--] Month: 0.0044% -0.017%  
[--] Months: 0.0044% -0.0032%  
[--] Year: 0.0044% -0.0044%  
1-Year High: 0.058% on 2026-01-11  
1-Year Low: 0.0025% on 2025-09-14  
  
  
### Market Dominance: 0.00478%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$cgon/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$cgon/time-series/market_dominance.tsv)  
Current Value: 0.00478%  
Daily Average: 0%  
1-Year High: 0.07% on 2025-03-31  
1-Year Low: 0.00198% on 2025-04-08  
  
  
### Market Cap: $4,216,317,264
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$cgon/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$cgon/time-series/market_cap.tsv)  
Current Value: $4,216,317,264  
Daily Average: $2,626,349,737  
[--] Week: $4,216,317,264 +1.30%  
[--] Month: $4,255,150,678 -5.90%  
[--] Months: $4,255,150,678 +118%  
[--] Year: $4,255,150,678 +96%  
1-Year High: $4,720,325,402 on 2026-01-21  
1-Year Low: $1,188,220,769 on 2025-04-08

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

CG Oncology, Inc. (CGON)

CG Oncology (CGON) sees soaring social dominance and sentiment following positive bladder cancer trial data. Guggenheim initiates coverage with a 'Buy' rating and $90 target, fueling investor optimism.

About CG Oncology, Inc.

CG Oncology, Inc. is a biopharmaceutical company focused on developing treatments for bladder cancer.
CG Oncology, Inc. uses the ticker $CGON for trading. Listed in the Stocks category.

Insights

  • CG Oncology, Inc. (CGON) social dominance is up 176% from the previous week.
  • CG Oncology, Inc. (CGON) Galaxy Score™ is up 61.54% from the previous week.
  • CG Oncology, Inc. (CGON) sentiment is up 100% from the previous week.
  • CG Oncology, Inc. (CGON) engagements is up 38.55% from the previous week.
  • CG Oncology, Inc. (CGON) mentions is up 13.01% from the previous week.
  • CG Oncology, Inc. (CGON) posts created is up 184.62% from the previous week.

Price: $51.50

Price Line Chart
Price 24-Hour Time-Series Raw Data
The stock price is likely increasing due to positive clinical trial data, high sentiment, and a surge in social engagement, supported by a Guggenheim buy rating and target price of $90, despite a recent minor price drop.

24-Hour: -1.14% 7-Day: 3.71% 30-Day: -5.9%

1-Year High: $57.10 on 2026-01-21
1-Year Low: $15.60 on 2025-04-08

AltRank: [-----]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
CG Oncology, Inc. (CGON) is currently AltRank #1,638 based on combined combined social and market metrics Daily Average: [---]
[--] Week: [-----] +1,498
[--] Month: [-----] +682
[--] Months: [-----] +833
[--] Year: [-----] +533
1-Year High: [-----] on 2025-07-05
1-Year Low: [--] on 2025-04-28

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] +16
[--] Month: [--] [---]
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-06-02
1-Year Low: [--] on 2025-04-01

Engagements: [---] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [------]
[--] Week: [------] +39%
[--] Month: [-------] -58%
[--] Months: [---------] -48%
[--] Year: [---------] +1.30%
1-Year High: [-------] on 2025-08-10
1-Year Low: [---] on 2026-02-15

Engagements by network (24h): TikTok: [--] Reddit: [--] X: [---] YouTube: [--]

Mentions: [--] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] +13%
[--] Month: [---] -22%
[--] Months: [-----] +26%
[--] Year: [-----] +113%
1-Year High: [---] on 2026-01-10
1-Year Low: [--] on 2025-09-14

Mentions by network (24h): TikTok: [--] Reddit: [--] X: [--] YouTube: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning CG Oncology, Inc. (CGON) in the last [--] hours which is down 53% from [--] in the previous [--] hours Daily Average: [--]
[--] Week: [---] +8.80%
[--] Month: [---] -25%
[--] Months: [-----] -7%
[--] Year: [-----] +99%
1-Year High: [---] on 2026-01-10
1-Year Low: [--] on 2025-03-05

Sentiment: 100%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 100%
Daily Average: 77%
[--] Week: 100% +50%
[--] Month: 100% +18%
[--] Months: 100% +18%
[--] Year: 100% +45%
1-Year High: 100% on 2025-02-20
1-Year Low: 6% on 2025-03-03

Most Supportive Themes:

  • Positive Clinical Trial Results: (70%) CG Oncology's recent positive clinical trial data for its bladder cancer therapy is a significant driver of investor confidence and positive sentiment.
  • Increased Social and Trading Activity: (22%) A notable surge in trading volume and social media engagement indicates growing interest and attention towards CGON.
  • Guggenheim Buy Rating: (8%) Guggenheim's initiation of coverage with a 'Buy' rating and a $90 price target provides a strong endorsement and potential upside for the stock.

Most Critical Themes:

  • Analyst Downgrade: (8%) An unspecified analyst downgrade is creating negative pressure on the stock, despite the otherwise positive news.

Social Dominance: 0.00292%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00292%
Daily Average: 0.011%
[--] Week: 0.00276% +0.00176%
[--] Month: 0.0044% -0.017%
[--] Months: 0.0044% -0.0032%
[--] Year: 0.0044% -0.0044%
1-Year High: 0.058% on 2026-01-11
1-Year Low: 0.0025% on 2025-09-14

Market Dominance: 0.00478%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00478%
Daily Average: 0%
1-Year High: 0.07% on 2025-03-31
1-Year Low: 0.00198% on 2025-04-08

Market Cap: $4,216,317,264

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $4,216,317,264
Daily Average: $2,626,349,737
[--] Week: $4,216,317,264 +1.30%
[--] Month: $4,255,150,678 -5.90%
[--] Months: $4,255,150,678 +118%
[--] Year: $4,255,150,678 +96%
1-Year High: $4,720,325,402 on 2026-01-21
1-Year Low: $1,188,220,769 on 2025-04-08

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

CG Oncology, Inc. (CGON)
/topic/cg-oncology